AJOVY (fremanezumab), competing against Aimovig (Amgen/Novartis) and Ajovy (Teva) in the CGRP migraine prevention class, is growing and demonstrates Teva's capacity to develop innovative peptide-adjacent biologics
This sufficiently powered clinical study did not find a beneficial effect of linagliptin versus placebo on albuminuria in patients with T2DM, although exploratory analyses indicated more responders and fewer non-responders in terms of UACR in the linagliptin group
Understanding Whats Causing the Injection Stinging Pain There are different sensations when injecting any drug
Research indicates it reduces pro-inflammatory cytokines like TNF-alpha, IL-6, and IL-1 beta, without broadly suppressing immune function the way corticosteroids do
International agencies can assist by standardizing data standards, trial design, and adverse-event reporting
-